Lucintel Forecasts Ultrasound Gel Market to Reach $XX Billion by 2028
According to the recent study the ultrasound gel market is projected to reach an estimated $XX billion by 2028 from $XX billion in 2023, at a CAGR of 3% to 5% from 2023 to 2028. Growth in this market is primarily driven by growing usage of ultrasound gel in medical procedures as a binding agent, increasing usage of ultrasound for detection of diseases considering it less harmful compared to other imaging system, and availability of less expensive ultrasound gels.
Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in ultrasound gel market by product type (non-sterile and sterile), application (pregnancy ultrasound, organ ultrasound, and others), end use industry (hospital, clinic, diagnostic center, ambulatory center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Download sample report by clicking onbelow linkhttps://www.lucintel.com/ultrasound-gel-market.aspx
“Non-sterile market is expected to remain the largest segment during the forecast period.”
Based on product type, the ultrasound gel market is segmented into non-sterile and sterile. Lucintel forecasts that the non-sterile market is expected to remain the largest segment due to the increasing usage of external probe techniques that require low level of cleaning and disinfection for the diagnosis of gallbladder problems, cancers, and intestinal diseases and rising demand for non-sterile gel application to give pregnant ladies a clear view of the foetus.
“Within the ultrasound gel market, the hospital segment is expected to remain the largest end use industry”
Based on end use industry the hospital segment is expected to witness the highest growth over the forecast period due to the growing prevalence of problems such as acute abdominal pain, chest pain, and vascular problems that requires ultrasound as a primary diagnostic tool and usage of the ultrasound device in follow-up visits of patients, and increa